Geron Corp. Shares Display Perfect Head-and-Shoulders Pattern
What a site, Geron Corp. (NASDAQ:GERN) shares are displaying a beautiful head-and-shoulders pattern. From $5 a share in May to $9 in July then back down to $5 level today. Stem Cells were all the rage a few months ago, now they've just lost steam.
Geron is the company that made news with its stem cell therapy showing benefits in treating spine injuries in rodents' cervical region.
Geron's experimental therapy, GRNOPC1 had earlier run into safety problems as rodents being treated for spinal cord injury in the thoracic region developed a kind of tumor in the animal studies, which prompted the U.S. health regulator to put an early-stage trial on hold.
Data from the current animal study could be used to release the clinical hold and testing the therapy in patients with spinal injuries in the cervical region, the Food and Drug Administration had said in October.
Last month, the stem cell research company said GRNOPC1, reduced tissue damage and improved recovery of nerve function in the proof-of-concept study.
Seven days after injury, rodents treated with GRNOPC1 did not have a cavity in the spinal cord, had more preserved nerve units, and more neurons with their protective covering myelin, Geron said.
Back to the head-and-shoulders pattern, here's a larger view of the chart thanks to finviz.com. So could the stock be a bottom? You make the call.
Disclaimer: No positions in GERN.
Best of the Blogs
Scanning and identifying the best blog entries every hour
- "Erdogan Is The Father Of ISIS" - New Documentary Outlines Turkey's Support Of The Islamic State | ZeroHedge
- EXCLUSIVE: Another ZERO HEDGE Insider Leak | ZeroHedge
- Focused On The Wrong End Of Oil | ZeroHedge
- "Why Our Children Should Hate Us" - Read The Lance Simmens Article Banned By The Huffington Post | ZeroHedge
- US to Undermine Russia’s Gas Monopoly in Europe | Financial Sense
- Hillary Will Be The Least Of Your Worries - America Has Economic Diarrhea | ZeroHedge
- Blistering 7 Year Auction Stops Through, Driven By Surge In Foreign Central Bank Demand | ZeroHedge
The most relevant financial news and articles from the Internets
- Amazon Prime members can save big on a great pair of Sennheiser headphones right... | Business Insider
- The financial editor of NBC's Today Show shares her best advice to start... | Business Insider
- Amazon isn't just growing revenue anymore — it's growing profits... | Business Insider
- The Canadian government slighted the indigenous community... | Business Insider
- Allison Janney revived her 'West Wing' character to fill in for the... | Business Insider
- Doing this for 5 minutes every day can help people who suffer from... | Business Insider
- Police say 25-year-old Apple employee died of self-inflicted gunshot... | Business Insider